Completed NA INTERVENTIONAL 2-arm NCT00833547

Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia

Sponsor: Beth Israel Deaconess Medical Center

Updated 7 times since 2017 Last updated: Aug 26, 2014 Started: Sep 30, 2006 Primary completion: Sep 30, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Schizophrenia and is currently completed. Beth Israel Deaconess Medical Center leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Sep 2023 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Sumitomo Pharma America, Inc.

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States